JITC

Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung
Elizabeth Dudnik, Samuel Kareff, Mor Moskovitz, Chul Kim, Stephen V Liu, Anastasiya Lobachov, Teodor Gottfried, Damien Urban, Alona Zer, Ofer Rotem, Amir Onn, Mira Wollner, Jair Bar

Journal for ImmunoTherapy of Cancer Feb 2021, 9 (2) e001999; DOI: 10.1136/jitc-2020-001999
'Off-the-shelf’ allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies
Debottam Sinha, Sriganesh Srihari, Kirrliee Beckett, Laetitia Le Texier, Matthew Solomon, Archana Panikkar, George R Ambalathingal, Lea Lekieffre, Pauline Crooks, Sweera Rehan, Michelle A. Neller, Corey Smith, Rajiv Khanna

Journal for ImmunoTherapy of Cancer Feb 2021, 9 (2) e001608; DOI: 10.1136/jitc-2020-001608
Differential combination immunotherapy requirements for inflamed (warm) tumors versus T cell excluded (cool) tumors: engage, expand, enable, and evolve
Kellsye P Fabian, Michelle R Padget, Rika Fujii, Jeffrey Schlom, James W Hodge

Journal for ImmunoTherapy of Cancer Feb 2021, 9 (2) e001691; DOI: 10.1136/jitc-2020-001691
Non-canonical PD-1 signaling in cancer and its potential implications in clinic
Haoran Zha, Ying Jiang, Xi Wang, Jin Shang, Ning Wang, Lei Yu, Wei Zhao, Zhihua Li, Juan An, Xiaochun Zhang, Huoming Chen, Bo Zhu, Zhaoxia Li

Journal for ImmunoTherapy of Cancer Feb 2021, 9 (2) e001230; DOI: 10.1136/jitc-2020-001230
Statins act as transient type I interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors
Shirley Tenesaca, Marcos Vasquez, Maite Alvarez, Itziar Otano, Myriam Fernandez-Sendin, Claudia Augusta Di Trani, Nuria Ardaiz, Celia Gomar, Angela Bella, Fernando Aranda, José Medina-Echeverz, Ignacio Melero, Pedro Berraondo

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e001587; DOI: 10.1136/jitc-2020-001587
Chemical priming of natural killer cells with branched polyethylenimine for cancer immunotherapy
Seung Hee Choi, Hye Jin Kim, Joo Dong Park, Eun-Su Ko, Minwook Lee, Dae-Keum Lee, Jin-Ho Choi, Hye Jung Jang, Isaac Kim, Hae-Yun Jung, Keun-Hong Park, Kyung-Soon Park

Journal for ImmunoTherapy of Cancer Aug 2022, 10 (8) e004964; DOI: 10.1136/jitc-2022-004964
Phase II study of durvalumab (anti-PD-L1) and trametinib (MEKi) in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
Benny Johnson, Cara L Haymaker, Edwin R Parra, Luisa Maren Solis Soto, Xuemei Wang, Jane V Thomas, Arvind Dasari, Van K Morris, Kanwal Raghav, Eduardo Vilar, Bryan K Kee, Cathy Eng, Christine M Parseghian, Robert A Wolff, Younghee Lee, Daniele Lorenzini, Caddie Laberiano-Fernandez, Anuj Verma, Wenhua Lang, Ignacio I Wistuba, Andrew Futreal, Scott Kopetz, Michael J Overman

Journal for ImmunoTherapy of Cancer Aug 2022, 10 (8) e005332; DOI: 10.1136/jitc-2022-005332
Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments
Sylvain Nguyen, Mathieu F Chevalier, Sulayman Benmerzoug, Valérie Cesson, Anna K Schneider, Sonia-Cristina Rodrigues-Dias, Florence Dartiguenave, Ilaria Lucca, Patrice Jichlinski, Beat Roth, Denise Nardelli-Haefliger, Laurent Derré

Journal for ImmunoTherapy of Cancer Aug 2022, 10 (8) e004880; DOI: 10.1136/jitc-2022-004880
Antitumor efficacy of ⁹⁰Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors
Hemanth K Potluri, Carolina A Ferreira, Joseph Grudzinski, Christopher Massey, Eduardo Aluicio-Sarduy, Jonathan W Engle, Ohyun Kwon, Ian R Marsh, Bryan P Bednarz, Reinier Hernandez, Jamey P Weichert, Douglas G McNeel

Journal for ImmunoTherapy of Cancer Aug 2022, 10 (8) e005060; DOI: 10.1136/jitc-2022-005060
Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance
Han-Ying Cheng, Chia-Hsin Hsieh, Po-Han Lin, Yu-Tung Chen, Dennis Shin-Shian Hsu, Shyh-Kuan Tai, Pen-Yuan Chu, Muh-Hwa Yang

Journal for ImmunoTherapy of Cancer Aug 2022, 10 (8) e004832; DOI: 10.1136/jitc-2022-004832

Main menu

JITC

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

JITC

Pages